Agenus Inc.

15 Days Left

Class Action Period:
January 23, 2023 - July 17, 2024

Lead Plaintiff Deadline:
November 05, 2024

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

First Name

Last Name

Phone

Street Address

City

State

Zip

Shares Purchased

Purchase Date

Estimated Loss

The submission of this form does not create an attorney-client relationship.

Allegations

The filed complaint alleges that Agenus Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the combination therapy of their immuno-oncology products, botensilimab and balstilimab was less effective than the defendants had led investors to believe; (ii) accordingly, botensilimab and balstilimab’s clinical results, as well as their regulatory and commercial prospects, were overstated; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Agenus purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Agenus during the relevant time frame, you have until November 05, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.